On November 17, 2008 Cancer Research Technology (CRT) reported that it is hosting thirty-five industrial scientists, representing the research and drug discovery functions of eighteen of the world’s top pharmaceutical and biotechnology companies, during the AACR (Free AACR Whitepaper)-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting in Boston (Press release, Cancer Research Technology, NOV 17, 2009, View Source [SID1234523530]). The objective of the "Science & Seafood" luncheon is to introduce scientific leaders responsible for companies’ cancer drug discovery and development to Cancer Research UK and Cancer Research Technology’s drug discovery programmes. The event features presentations by two of the charity’s leading translational scientists, Professors Paul Workman and Peter Parker.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cancer Research UK – the world’s largest independent organisation dedicated to cancer research, invested £303 million last year (2008/09) on research.